Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Multimodal Melasma Treatment with Chemical Peels, Microneedling, and PRP
Description
The speaker emphasized that melasma should be treated as a multimodal condition because it reflects both epidermal pigmentation and underlying photodamage, including dermal inflammation, vascular changes, and basement membrane disruption. Standard management begins with photoprotection, hydration, topical therapy such as triple-combination bleaching cream, and sometimes oral tranexamic acid, with procedures added if response is inadequate. For chemical peels, the focus was on gentle, superficial approaches in skin of color, using priming with sunscreen, retinoids, and sometimes hydroquinone, avoiding active dermatitis, and minimizing inflammation to reduce post-inflammatory hyperpigmentation. Evidence suggests no single peel is clearly superior, though sequential peels may outperform single agents; gentler options such as salicylic acid in polyethylene glycol and mandelic acid were highlighted, while medium-depth peels should generally be avoided. Microneedling was presented as useful both for transdermal drug delivery and for dermal remodeling, with greater benefit when combined with agents such as tranexamic acid; radiofrequency microneedling may also help prevent relapse. Platelet-rich plasma was described as promising but still experimental, with some studies showing added benefit as an adjunct to topical therapy, but overall more research is needed. The speaker concluded with a practice approach centered on gentle procedures combined with topical and oral therapy, using microneedling and superficial peels regularly, and reserving more aggressive options for select recalcitrant cases.
View moreConclusions
- Melasma is best approached with multimodal therapy that combines photoprotection and topicals with selected procedures rather than relying on a single intervention.
- Superficial chemical peels can improve melasma, but evidence does not clearly show one peel formulation is superior, so gentler agents are generally preferred, especially in skin of color.
- Pre-procedure priming, careful patient selection, and minimizing inflammation are important to reduce complications such as overpenetration and post-inflammatory hyperpigmentation.
- Microneedling appears to help melasma both by enhancing transdermal delivery of topical agents and by inducing epidermal and dermal remodeling.
- Microneedling results tend to improve with repeated treatments and are best when combined with adjunctive topical therapies such as tranexamic acid.
- Radiofrequency microneedling and deeper dermal-targeting approaches may be particularly promising for reducing relapse, but they need more study.
- Platelet-rich plasma may reduce melasma severity when used intradermally, but the evidence is still limited and inconsistent, so it should be considered experimental or adjunctive.
- Deep chemical peels, including phenol-croton oil approaches, may produce durable remission in selected refractory melasma cases by remodeling the reticular dermis.
- Overall, the presentation concludes that gentle procedural treatments can accelerate improvement, while more aggressive or less standardized options require further research before routine use.
- Ann Dermatol. 2024;36:125-134.
- International Journal of Dermatology 2025; 64: 499-512.
- J Am Acad Dermatol 2019;81:313-24.
- J. Cosmet. Dermatol. 2020;19:2812–2819.
- Dermatol Surg 2024;50:656–661.
- Dermatol Surg 2008;34:891–899.
- Dermatol Surg 2006;32:372–375.
- J Am Acad Dermatol 2024;91:336-338.
- Dermatol Surg 2012;38:1107–1108.
- Aesthetic Surgery Journal 2016;36:168–170.
- JAMA Dermatol 2014;150:68-72.
- Indian J Dermatol Venereol Leprol 2019;85:638-41.
- J Am Acad Dermatol 2022;86:797-810.
- Dermatol Surg 2022; 48:131-134.